Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Feature

Pain Management Conference 2008

Posted on: 11 Jul 08

Summary

The development of innovative therapeutics and complimentary technologies for the effective management of pain 7th – 8th October 2008, BSG Conference Centre, London, UK.

“The market revenue from drug-delivery technologies in the pain management market is US$1.9billion, growing at a CAGR of 6.5% to reach US$2.6billion by the end of 2012.” [‘Pain Market Outlook Report’ - Business Insights] - Dr Emanuele Sher, Research Advisor, Pain Migraine Team Leader, Eli Lilly & Co - Dr Mark Field, Global Research & Development, Pfizer - Dr Adnan Al-Kaisy, Senior Physician, Pain Management Clinic London - Professor Peter McNaughton, Professor of Pharmacology, University of Cambridge - Professor Praveen Anand, Professor of Clinical Neurology, Imperial College London - Dr Dic Williams, Research Fellow, Pain Therapeutics, Pfizer - Dr John Connell, Leader in Clinical Pharmacodynamics & Project Manager, Icon Development Solutions - Professor Anthony Jones, Professor of Neuro-Rheumatology, University of Manchester - Professor Anthony Dickenson, Specialist in Pain Mechanisms, Professor of Neuro-Pharmacology, UCL - Professor Martin Koltzenburg, Professor Neuro-Physiology, UCL This expected growth rate of 6.5% can be realised by addressing innovation within the industry - where drug-discovery can be developed through the utilisation of novel methods in drug-applications for the management of pain. Speciality Pharma business-models have arisen to catalyse this growth and recent breakthroughs by several companies within the sector - specifically through clinical trials, reflect the realisation of this potential. The next stage for such companies will be to capture niche markets in pain management in order to develop their portfolio of products which include a combination of formulated active entities working through conventional oral administration or in conjunction with novel or improved drug-specific technologies e.g. drug-delivery systems, or drug-specific devices. This, Visiongain’s 5th Annual Pain Management conference will create the appropriate environment for an exchange of ideas occurring at the corporate level, whilst also raising the awareness of potentially novel scientific developments in pain research, in working towards the next generation of pain management products in a market that is growing rapidly. The world market for pain therapeutics is currently valued at $31.1bn and revenues are forecasted to increase just under $40bn in 2012. But what will it be in 2022? Do you know what the drivers and restraints of the market are? This conference not only offers a unique opportunity to meet with your peers and discuss this but also details what strategies can be used to maximize profits from the drivers and restraints, with SWOT analysis and expert advice. Ensure your organisation is successful in this market by booking your place at this conference today. The non-narcotics market is set to dominate the pain market over the next 5 years, accounting for almost 36.8% of market revenues by 2012. This market is set for growth right through the next 15 years and by attending this conference you will be ideally placed to benefit from this growth. Find out who are the major companies involved in the pain market today and in the future. And what R&D opportunities exist for 'new-comers' to the pain pharmaceutical market. Analyse the pipeline of pain products and how it effects your future product launches and partners. The pain management conference 2008 focuses on the major market areas including: 1. Anti-Migraine market 2. Anti-Rheumatics non-steroidal market 3. Narcotics market 4. Non-narcotics market Reasons to register today • To gain a current and focused overview of the pain management industry that exists today • To assess and forecast the future of innovation in the pain management industry • To develop an up-to-date understanding of the product management framework created by Speciality Pharma business-models • To explore integrated business-network solutions in order to troubleshoot Pharma pipeline projects associated with pain management • To determine the viability of current research into revealing the mechanisms of pain and the potential this could have on novel drug development and drug-delivery technologies • To evaluate other more unconventional and/or controversial methods in pain management • To create a suitable networking environment for the appropriate senior business developers and scientific leaders in the industry - in order to facilitate an exchange of ideas and an integration in approaches to pain management deliverables Who should attend? CEOs, Directors, Senior Business Developers, Senior Scientific Officers, Senior Therapeutics and Pain Management Leaders, and Consultants from: • Pharmaceutical and Biotechnology companies • The Speciality Pharma industry • Drug-delivery technology companies • The Generic-based Pharma/Biotech industry • Contract Research Organisations • Regulatory Bodies • Outsourcing-based organisations: Manufacturing and Equipment based • Investment and Finance-based companies • Marketing-based organisations PLUS =========================================== Would you and your company like to run an interactive one-day workshop at the event? Pre-conference workshop, Wednesday 15th October 2008 Running a half day workshop will give you a great exposure to leading key practitioners and decision makers and will give you a chance to have direct influence over a select group of leading experts. In a workshop a selected number of delegates from the conference will meet for brainstorming and group discussion, and by leading the workshop you will have the elevated stature of possibility to inspire the participants as well as the topic, to a great extent. To suggest your potential topic and enquire about how you and your company could take advantage of this please contact andrea.charles@visiongain.com =========================================== If you only attend one event this year make sure it is the conference that will guarantee your success for the next few years. Places at this conference are limited and are issued on a strict first come, first served basis. Contact me now to reserve your seat. PRICING - 2 day Conference only ticket - available for only GBP £1299 - If you would like to send more than 1 person then take advantage of the 3 for 2 offer. Send 3 people but only pay for 2. Excellent networking opportunities. ORDERING Ordering is simple! All you need to do to book your place is contact me now. You can either call me on TEL: +44 (0)207 549 1935 or email mailto: pharma.reports1@conferencesandreports.com Plus our new virtually round-the-clock customer service means we are available to assist you with your order even longer.
Call us on +44 (0)207 549 1935
between the hours of 9am to 5.30pm GMT Monday to Friday or for assistance outside of these hours call +1 866 9563001 between the hours of 9am and 5.30 pm PST. Please feel free to contact me should you have any questions, or wish to purchase a place, I look forward to hearing from you. Ewa Malkowska Emarketing Executive Visiongain Ltd. BSG House,

PharmiWeb Editor

Last updated on: 27/08/2010 11:40:18

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.